Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

111.71 +1.76 (+1.60%)

Streaming Delayed Price Updated: 11:51 AM EDT, Mar 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

53 54 Next >

P/E Ratio Insights for Abbott Laboratories ↗

September 22, 2023

Via Benzinga

3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought ↗

September 21, 2023

Tech stocks were the primary fuel for a decades-long bull market, and these three Nasdaq stocks to buy can lead the market forward.

Via InvestorPlace

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

This Is What Whales Are Betting On Abbott Laboratories ↗

September 20, 2023

Via Benzinga

(ABT) - Analyzing Abbott Laboratories's Short Interest ↗

September 20, 2023

Via Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today ↗

September 14, 2023

Via Benzinga

Is Abbott Laboratories a Buy? ↗

September 12, 2023

If you're willing to invest with the right mindset, it could be a great option.

Via The Motley Fool

Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch ↗

September 15, 2023

Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood...

Via Benzinga

2 Dividend Kings to Buy on the Dip and Hold Forever ↗

September 15, 2023

Don't ignore these stocks just because the rest of the market is.

Via The Motley Fool

Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year ↗

September 15, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money.

Via Benzinga

Could Abbott Laboratories Stock Help You Become a Millionaire? ↗

September 15, 2023

One promising area of its business is diabetes care, which experienced significant growth this year.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 11, 2023

Via Benzinga

Less Is More: Abbott’s Approach to Packaging Innovation

September 11, 2023

Via ACCESSWIRE

Abbott Joins Billion Dollar Roundtable

September 07, 2023

Via ACCESSWIRE

Looking At Abbott Laboratories's Recent Unusual Options Activity ↗

September 06, 2023

Via Benzinga

3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing ↗

September 09, 2023

You'll want to hold on to these players for the long term.

Via The Motley Fool

September Rally? 3 Healthcare Stocks to Buy Before Liftoff. ↗

September 08, 2023

The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term.

Via InvestorPlace

The 3 Best Pharma Stocks to Buy Now: September 2023 ↗

September 08, 2023

There are pharma stocks to buy for each type of investor. This article explores the best options in the industry.

Via InvestorPlace

Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip? ↗

September 05, 2023

Its latest pullback could be an opportunity to buy a legendary dividend stock before it begins a long upward climb.

Via The Motley Fool

2 Incredible Stocks to Buy on the Dip ↗

September 02, 2023

Today's bargain may pay off big down the road.

Via The Motley Fool

The 3 Most Promising Healthcare Stocks to Own Now ↗

September 01, 2023

These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.

Via InvestorPlace

$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today ↗

September 01, 2023

Via Benzinga

Peering Into Abbott Laboratories's Recent Short Interest ↗

August 31, 2023

Via Benzinga

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond ↗

August 31, 2023

These reliable dividend payers are a fantastic opportunity for investors to generate passive income.

Via The Motley Fool

A Significant Reversal is in Sight for These 5 Med Tech Companies

August 30, 2023

Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.

Via MarketBeat

How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year ↗

August 29, 2023

Under bipartisan Congressional legislation, baby formula manufacturers must notify the U.S.

Via Benzinga

5 Good Reasons it's Time to Buy High-Yield Dividend King 3M

August 29, 2023

3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up

Via MarketBeat

Topics Lawsuit

1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling ↗

August 28, 2023

Some of the world's most successful investors are focusing on stocks.

Via The Motley Fool

U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio ↗

August 24, 2023

Looking for stocks to buy amid the U.S. credit rating downgrade? Look no further. These companies have you covered.

Via InvestorPlace

Want Growing Passive Income? This Dividend King Could Be a Smart Buy ↗

August 23, 2023

The company boasts one of the longest dividend growth streaks in the healthcare sector.

Via The Motley Fool

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.